140 related articles for article (PubMed ID: 36372298)
1. Deep learning-based predictions of clear and eosinophilic phenotypes in clear cell renal cell carcinoma.
Ohe C; Yoshida T; Amin MB; Uno R; Atsumi N; Yasukochi Y; Ikeda J; Nakamoto T; Noda Y; Kinoshita H; Tsuta K; Higasa K
Hum Pathol; 2023 Jan; 131():68-78. PubMed ID: 36372298
[TBL] [Abstract][Full Text] [Related]
2. Eosinophilic features in clear cell renal cell carcinoma correlate with outcomes of immune checkpoint and angiogenesis blockade.
Yoshida T; Ohe C; Ikeda J; Atsumi N; Ohsugi H; Sugi M; Higasa K; Saito R; Tsuta K; Matsuda T; Kinoshita H
J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34580162
[TBL] [Abstract][Full Text] [Related]
3. A deep-learning based artificial intelligence (AI) approach for differentiation of clear cell renal cell carcinoma from oncocytoma on multi-phasic MRI.
Nikpanah M; Xu Z; Jin D; Farhadi F; Saboury B; Ball MW; Gautam R; Merino MJ; Wood BJ; Turkbey B; Jones EC; Linehan WM; Malayeri AA
Clin Imaging; 2021 Sep; 77():291-298. PubMed ID: 34171743
[TBL] [Abstract][Full Text] [Related]
4. Deep learning can predict survival directly from histology in clear cell renal cell carcinoma.
Wessels F; Schmitt M; Krieghoff-Henning E; Kather JN; Nientiedt M; Kriegmair MC; Worst TS; Neuberger M; Steeg M; Popovic ZV; Gaiser T; von Kalle C; Utikal JS; Fröhling S; Michel MS; Nuhn P; Brinker TJ
PLoS One; 2022; 17(8):e0272656. PubMed ID: 35976907
[TBL] [Abstract][Full Text] [Related]
5. Spatially aware deep learning reveals tumor heterogeneity patterns that encode distinct kidney cancer states.
Nyman J; Denize T; Bakouny Z; Labaki C; Titchen BM; Bi K; Hari SN; Rosenthal J; Mehta N; Jiang B; Sharma B; Felt K; Umeton R; Braun DA; Rodig S; Choueiri TK; Signoretti S; Van Allen EM
Cell Rep Med; 2023 Sep; 4(9):101189. PubMed ID: 37729872
[TBL] [Abstract][Full Text] [Related]
6. Artificial intelligence prediction model for overall survival of clear cell renal cell carcinoma based on a 21-gene molecular prognostic score system.
Peng Q; Shen Y; Fu K; Dai Z; Jin L; Yang D; Zhu J
Aging (Albany NY); 2021 Mar; 13(5):7361-7381. PubMed ID: 33686949
[TBL] [Abstract][Full Text] [Related]
7. Features of increased malignancy in eosinophilic clear cell renal cell carcinoma.
Nilsson H; Lindgren D; Axelson H; Brueffer C; Saal LH; Lundgren J; Johansson ME
J Pathol; 2020 Dec; 252(4):384-397. PubMed ID: 32815150
[TBL] [Abstract][Full Text] [Related]
8. Clinical use of a machine learning histopathological image signature in diagnosis and survival prediction of clear cell renal cell carcinoma.
Chen S; Zhang N; Jiang L; Gao F; Shao J; Wang T; Zhang E; Yu H; Wang X; Zheng J
Int J Cancer; 2021 Feb; 148(3):780-790. PubMed ID: 32895914
[TBL] [Abstract][Full Text] [Related]
9. Deep learning and radiomics: the utility of Google TensorFlow™ Inception in classifying clear cell renal cell carcinoma and oncocytoma on multiphasic CT.
Coy H; Hsieh K; Wu W; Nagarajan MB; Young JR; Douek ML; Brown MS; Scalzo F; Raman SS
Abdom Radiol (NY); 2019 Jun; 44(6):2009-2020. PubMed ID: 30778739
[TBL] [Abstract][Full Text] [Related]
10. Large-scale transcriptome profiles reveal robust 20-signatures metabolic prediction models and novel role of G6PC in clear cell renal cell carcinoma.
Xu WH; Xu Y; Tian X; Anwaier A; Liu WR; Wang J; Zhu WK; Cao DL; Wang HK; Shi GH; Qu YY; Zhang HL; Ye DW
J Cell Mol Med; 2020 Aug; 24(16):9012-9027. PubMed ID: 32567187
[TBL] [Abstract][Full Text] [Related]
11. Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma.
Sun Z; Li T; Xiao C; Zou S; Zhang M; Zhang Q; Wang Z; Zhan H; Wang H
World J Surg Oncol; 2022 Apr; 20(1):120. PubMed ID: 35422048
[TBL] [Abstract][Full Text] [Related]
12. Identification of a claudin-low subtype in clear cell renal cell carcinoma with implications for the evaluation of clinical outcomes and treatment efficacy.
Zhang C; Li Y; Qian J; Zhu Z; Huang C; He Z; Zhou L; Gong Y
Front Immunol; 2022; 13():1020729. PubMed ID: 36479115
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a prognostic immune-associated gene signature in clear cell renal cell carcinoma.
Shen C; Liu J; Wang J; Zhong X; Dong D; Yang X; Wang Y
Int Immunopharmacol; 2020 Apr; 81():106274. PubMed ID: 32044664
[TBL] [Abstract][Full Text] [Related]
14. Screening and identification of prognostic genes associated with eosinophilic features of clear cell renal cell carcinoma.
Guo T; Jiang L; Wang T; Zhang J; Liu Y; Wang X; Zhang N; Chen S; Wang X
Heliyon; 2023 Jun; 9(6):e16479. PubMed ID: 37274638
[TBL] [Abstract][Full Text] [Related]
15. Deep learning using contrast-enhanced ultrasound images to predict the nuclear grade of clear cell renal cell carcinoma.
Bai Y; An ZC; Li F; Du LF; Xie TW; Zhang XP; Cai YY
World J Urol; 2024 Mar; 42(1):184. PubMed ID: 38512539
[TBL] [Abstract][Full Text] [Related]
16. Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.
Zhou L; Fang H; Guo F; Yin M; Long H; Weng G
J Clin Lab Anal; 2022 Aug; 36(8):e24582. PubMed ID: 35808868
[TBL] [Abstract][Full Text] [Related]
17. Construction of a Novel Immune-Related lncRNA Pair Signature with Prognostic Significance for Kidney Clear Cell Renal Cell Carcinoma.
Sun JX; Xia QD; Liu CQ; Xu JZ; Xun Y; Lu JL; Hu J; Wang SG
Dis Markers; 2021; 2021():8800358. PubMed ID: 34512816
[TBL] [Abstract][Full Text] [Related]
18. A four-gene signature predicts survival in clear-cell renal-cell carcinoma.
Dai J; Lu Y; Wang J; Yang L; Han Y; Wang Y; Yan D; Ruan Q; Wang S
Oncotarget; 2016 Dec; 7(50):82712-82726. PubMed ID: 27779101
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of CENPM is associated with poor clinical outcome and suppression of immune profile in clear cell renal cell carcinoma.
Zhang ZC; Liu YF; Xi P; Nie YC; Sun T; Gong BB
Hereditas; 2023 Jan; 160(1):1. PubMed ID: 36635779
[TBL] [Abstract][Full Text] [Related]
20. A Novel miRNA-Based Model Can Predict the Prognosis of Clear Cell Renal Cell Carcinoma.
Wu J; Zhang F; Zhang J; Sun Z; Hao C; Cao H; Wang W
Technol Cancer Res Treat; 2021; 20():15330338211027923. PubMed ID: 34159861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
